UB is sponsoring a virtual talk on “The COVID-19 Vaccines: Science vs. Anti-science” by prominent vaccine scientist and “misinformation antagonist” Peter J. Hotez, MD, PhD, on June 9 at noon.
A University at Buffalo expert on the behavioral treatment of chronic pain disorders has been awarded $3.3 million from the National Institutes of Health to conduct a five-year clinical study of drug-free behavioral treatments for chronic pelvic pain in men and women.
Jeffrey M. Lackner, PsyD, professor of medicine and chief of the Division of Behavioral Medicine, has been elected to the Academy of Behavioral Medicine Research (ABMR).
A joint study between researchers at the University at Buffalo and UCLA demonstrates for the first time that a specific type of cognitive behavioral therapy (CBT) that teaches information processing skills can modulate key components of the brain-gut-microbiome axis in some of the most severe irritable bowel syndrome (IBS) patients.
Two medical fellows, four medical residents and two medical students earned honors for outstanding poster presentations at the Office of Graduate Medical Education’s second annual Celebration of Scholarship.
Eight faculty members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 16th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
Twelve projects and their researchers were recognized as best in their respective categories during the Department of Medicine’s sixth annual Research Day.
